Vitamin b12 and Thrombotic microangiopathy - a phase IV clinical study of FDA data
Summary:
Thrombotic microangiopathy is reported as a side effect among people who take Vitamin b12 (cobalamin), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Vitamin D3, and have Nausea.
The phase IV clinical study analyzes which people have Thrombotic microangiopathy when taking Vitamin b12. It is created by eHealthMe based on reports of 119,611 people who have side effects when taking Vitamin b12 from the FDA, and is updated regularly.
What is Vitamin b12?
Vitamin b12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 121,681 Vitamin b12 users. Check the latest studies of Vitamin b12.
What is Thrombotic microangiopathy?
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury) is found to be associated with 469 drugs and 672 conditions by eHealthMe. Check the latest studies of Thrombotic microangiopathy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
119,611 people reported to have side effects when taking Vitamin b12.
Among them, 13 people (0.01%) have Thrombotic microangiopathy.

Among these 13 people:
How long have people been on Vitamin b12 when they have Thrombotic microangiopathy? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 100 %
What is the gender of people who have Thrombotic microangiopathy when taking Vitamin b12? *
- female: 38.46 %
- male: 61.54 %
What is the age of people who have Thrombotic microangiopathy when taking Vitamin b12? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 15.38 %
- 50-59: 7.69 %
- 60+: 76.92 %
What are other drugs people take besides Vitamin b12? *
- Vitamin D3: 8 people, 61.54%
- Abraxane: 7 people, 53.85%
- Plavix: 7 people, 53.85%
- Klonopin: 7 people, 53.85%
- Lovenox: 7 people, 53.85%
- Ondansetron: 7 people, 53.85%
- Eliquis: 6 people, 46.15%
- Heparin Lock Flush: 5 people, 38.46%
- Oxycodone: 4 people, 30.77%
- Tamsulosin: 4 people, 30.77%
What are other side effects people have besides Thrombotic microangiopathy? *
- Thrombocytopenia (decrease of platelets in blood): 9 people, 69.23%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 9 people, 69.23%
- White Blood Cell Count Decreased: 7 people, 53.85%
- Encephalopathy (functioning of the brain is affected by some agent or condition): 7 people, 53.85%
- Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 7 people, 53.85%
- Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 53.85%
- Lactic Acidosis (low ph in body tissues): 7 people, 53.85%
- Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 7 people, 53.85%
- Atrial Thrombosis (blood clot that develops in an artery): 7 people, 53.85%
- Febrile Neutropenia (fever with reduced white blood cells): 7 people, 53.85%
What are the existing conditions these people have? *
- Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 7 people, 53.85%
- Nausea (feeling of having an urge to vomit): 7 people, 53.85%
- Pain: 4 people, 30.77%
- Dyspnea (difficult or laboured breathing): 4 people, 30.77%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 30.77%
- Cough: 4 people, 30.77%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 30.77%
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 4 people, 30.77%
- Bladder Spasm: 4 people, 30.77%
- Sleep Disorder: 2 people, 15.38%
* Approximation only. Some reports may have incomplete information.
Do you take Vitamin b12 and have Thrombotic microangiopathy?
- Check whether Thrombotic microangiopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vitamin b12:
- Vitamin b12 (121,681 reports)
Thrombotic microangiopathy treatments and more:
- Thrombotic microangiopathy (11,852 reports)
How severe was Thrombotic microangiopathy and when was it recovered:
Expand to all the drugs that have ingredients of cobalamin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vitamin b12:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Thrombotic microangiopathy:
- Thrombotic microangiopathy (469 drugs)
Browse all the conditions that are associated with Thrombotic microangiopathy:
- Thrombotic microangiopathy (672 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cobalamin (the active ingredients of Vitamin b12) and Vitamin b12 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Anaemia Macrocytic and drugs of ingredients of fluticasone propionate; salmeterol xinafoate - 2 seconds ago
- Could Albuterol cause Multiple Allergies? - 2 seconds ago
- Tysabri and Joint Swelling for Women aged 40-49 - 10 seconds ago
- Tysabri and Swelling Of Fingers for Women aged 40-49 - 10 seconds ago
- Tysabri and Swelling Of A Joint for Women aged 40-49 - 10 seconds ago
- Tysabri and Knee Swelling for Women aged 40-49 - 11 seconds ago
- Tysabri and Hip Swelling for Women aged 40-49 - 11 seconds ago
- Tysabri and Finger Swelling for Women aged 40-49 - 11 seconds ago
- Myrbetriq and Parkinsonism for Women aged 60+ - 12 seconds ago
- Tysabri and Toe Swelling for Women aged 40-49 - 12 seconds ago